ARCHIVES

In Congress: Senate, House Reports List Priorities For NCI

This article is from The Cancer Letter archive.

Vol. 23 No. 31 | August 8, 1997

Download PDF Visit The Full Archive

Related Articles

Bristol-Myers Nominations Open

August 10, 1979

FDA’s Oncologic Drugs Advisory Committee recommended approval of three drugs for cancer, voted down one.

September 16, 2005

NCI Cooperative Group Clinical Trials Approved

July 31, 2009

Two-Drug Combination Extends Survival Of Mesothelioma

May 31, 2002

SSO Education Group Lists “Major Unmet Needs, Problems”

November 25, 1983

In Brief: Wyngaarden To Leave This summer; Fauci Probably Could Have The Job, May No Want It

April 28, 1989